
SQI Diagnostics Inc. — Investor Relations & Filings
SQI Diagnostics Inc. is a precision medicine and biotechnology company specializing in the discovery, development, and commercialization of innovative diagnostic solutions. The company utilizes proprietary technologies, including advanced microarray diagnostics, to evolve laboratory-based biomarker testing. SQI Diagnostics focuses on critical health areas, positioning itself as a leader in lung health and providing tests targeting organ transplant monitoring, autoimmune diseases, and infectious diseases. Its solutions serve the needs of the human diagnostic testing market and the pharmaceutical and biotechnology sectors for drug development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Report of exempt distribution (45-106F1) (amended).pdf | 2024-01-19 | English | |
| News release - English.pdf | 2023-05-31 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-05-31 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-05-31 | English | |
| Interim financial statements/report – English.pdf | 2023-05-31 | English | |
| Interim MD&A - English.pdf | 2023-05-31 | English |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AnorMED Inc.
Developed small molecule therapeutics for serious diseases,…
|
— | CA | Professional, scientific and te… |
|
ANTEOTECH LTD
Develops nanoglue technology for life sciences and lithium-…
|
ADO | AU | Professional, scientific and te… |
|
Anthem Biosciences Limited
Integrated CRAMS organization for drug discovery, developme…
|
ANTHEM | IN | Professional, scientific and te… |
|
APPLIED DNA SCIENCES INC
Develops and manufactures DNA-based technologies for geneti…
|
APDN | US | Professional, scientific and te… |
|
Aprea Therapeutics, Inc.
Clinical-stage biopharma developing cancer therapeutics via…
|
APRE | US | Professional, scientific and te… |
|
AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases…
|
397030 | KR | Professional, scientific and te… |
|
Aptahem AB
A clinical-stage biotech developing aptamer-based drugs for…
|
APTA | SE | Professional, scientific and te… |
|
APTAMER GROUP PLC
Develops custom affinity binders for research, diagnostics,…
|
APTA | GB | Professional, scientific and te… |
|
Aptevo Therapeutics Inc.
Clinical-stage biotech developing antibody-based immunother…
|
APVO | US | Professional, scientific and te… |
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
SQI Diagnostics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45470/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45470 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45470 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45470 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45470}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SQI Diagnostics Inc. (id: 45470)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.